MIR502 and neoplasm: Our results suggested that MIR502 might be modulated by NRF1 and function as a potential tumour suppressor by regulating the Hippo signalling pathway, which regulates downstream anti-apoptosis and pro-proliferation genes, therefore providing a novel candidate for developing MIR502-based therapeutic strategies.